WP
OM icon

Woodline Partners’s Outset Medical OM Stock Holding History

Woodline Partners’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Sell
292,437
-1,033,418
-78% -$4.24M ﹤0.01% 874
2025
Q4 		$4.92M Hold
1,325,855
– – 0.02% 627
2025
Q3 		$18.7M Buy
1,325,855
+71
+0% +$1.11K 0.09% 300
2025
Q2 		$25.5M Hold
1,325,784
– – 0.13% 227
2025
Q1 		$14.7M Buy
+1,325,784
New +$15.8M 0.1% 287
2023
Q1 		– Sell
-13,262
Closed -$5.14M – 740
2022
Q4 		$5.14M Sell
13,262
-3,235
-20% -$912K 0.07% 312
2022
Q3 		$3.94M Buy
16,497
+273
+2% +$73.1K 0.06% 341
2022
Q2 		$3.62M Sell
16,224
-4,429
-21% -$1.91M 0.06% 306
2022
Q1 		$14.1M Buy
20,653
+5,253
+34% +$3.16M 0.23% 132
2021
Q4 		$10.6M Buy
15,400
+1,521
+11% +$1.12M 0.15% 186
2021
Q3 		$10.3M Buy
13,879
+1,650
+13% +$1.12M 0.17% 160
2021
Q2 		$9.17M Buy
12,229
+2,594
+27% +$1.98M 0.17% 145
2021
Q1 		$7.86M Sell
9,635
-6
-0.1% -$4.63K 0.17% 149
2020
Q4 		$8.22M Buy
9,641
+1,269
+15% +$978K 0.22% 129
2020
Q3 		$6.28M Buy
+8,372
New +$6.88M 0.21% 112

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Woodline Partners's OM Position: Q1 2026 in Review

Woodline Partners reduced its Outset Medical (OM) stake by 78% in Q1 2026, selling an estimated $4.24M and leaving 292,437 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #874.

Woodline Partners first reported a position in OM in Q3 2020 and has held it in 15 quarters since. The position peaked at $25.5M in Q2 2025. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Woodline Partners held 292,437 shares of Outset Medical worth $1.12M as of Q1 2026.
  • Woodline Partners sold 1,033,418 Outset Medical shares in Q1 2026, an estimated $4.24M.
  • Outset Medical made up ﹤0.01% of Woodline Partners's portfolio in Q1 2026, its #874 holding.
  • Woodline Partners first reported a position in Outset Medical in Q3 2020 and has held it in 15 quarters since.
  • Woodline Partners's Outset Medical position peaked at $25.5M in Q2 2025.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.